Respiratory Practice Review, Issue 17

In this issue:

GOLD 2024 report
TSANZ position statement on treating IPF and PPF
Standards for the care of people with CF
Guidelines on using corticosteroids in sepsis, ARDS, and CAP
BTS Guideline: Pleural disease
Diagnosing and monitoring paediatric sleep-disordered breathing
Expanded access to lumacaftor and ivacaftor (Orkambi)
Pancrelipase (Panzytrat 25 000) delisted from PBS
Salbutamol (pms-Salbutamol) listed on PBS to address the current shortage
Safety advisory: Tiotropium bromide (Spiriva Respimat)
Durvalumab (Imfinzi) listed on PBS
Amendments to existing SARS-CoV-2 infection treatments
MBS update: Extension of temporary Pathology items for COVID-19
Impact of climate change and air pollution on lung function
Public consultation on COPD clinical care standard finalised
Updated COVID-19 vaccines effective against variants
Link between uncontrolled asthma and household disinfectants/cleaning products
COVID-19 resources
Conferences, workshops and CPD